|
MechanismPotassium channel blockers |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.AU |
First Approval Date14 Sep 2021 |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date30 Aug 1985 |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseClinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Lacuna Pharma Pty Ltd.
0 Patents (Medical) associated with Lacuna Pharma Pty Ltd.
100 Deals associated with Lacuna Pharma Pty Ltd.
100 Translational Medicine associated with Lacuna Pharma Pty Ltd.